Cedars-Sinai Medical CenterLos Angeles, California, United States
P26. Enhancing efficacy of dual therapy KRAS inhibitor and B7-H3 CAR T cells in preclinical pancreatic ductal adenocarcinoma models
Thursday, March 5, 202610:39 AM - 10:46 AM MST
P33. Recurrent Pancreatic Neuroendocrine Tumors in Lymph Node Negative Patients: A Multi-Institutional Risk-Score of Recurrence and Survival
Thursday, March 5, 202611:28 AM - 11:35 AM MST
